Parametrica Management’s Moderna MRNA Stock Holding History

Parametrica Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,187	Closed	-$1.38M	–	209
2020 Q4	$1.38M	Buy	+13,187	New	+$1.33M	0.85%	31
2020 Q3	–	Sell	-14,976	Closed	-$962K	–	133
2020 Q2	$962K	Buy	+14,976	New	+$820K	1.06%	24

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return

Parametrica Management's MRNA Position: Q1 2021 in Review

Parametrica Management sold out of Moderna (MRNA) in Q1 2021, closing a stake of 13,187 shares — an estimated $1.38M sold.

Parametrica Management first reported a position in MRNA in Q2 2020 and held it in 2 quarters. The position peaked at $1.38M in Q4 2020. 776 funds tracked by Wall St. Rank hold MRNA as of Q1 2021.

Parametrica Management reported no remaining Moderna position as of Q1 2021 after selling out during the quarter.
Parametrica Management sold 13,187 Moderna shares in Q1 2021, an estimated $1.38M.
Parametrica Management first reported a position in Moderna in Q2 2020 and held it in 2 quarters.
Parametrica Management's Moderna position peaked at $1.38M in Q4 2020.
776 funds tracked by Wall St. Rank held Moderna as of Q1 2021.

Based on Parametrica Management's 13F filing for Q1 2021, filed 14 May 2021.